Cargando…
Delivery of High-Quality Biomarker Assays
Biomarker measurements now support key decisions throughout the drug development process, from lead optimization to regulatory approvals. They are essential for documenting exposure-response relationships, specificity and potency toward the molecular target, untoward effects, and therapeutic applica...
Autor principal: | Swanson, Brian N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851636/ https://www.ncbi.nlm.nih.gov/pubmed/12364810 http://dx.doi.org/10.1155/2002/212987 |
Ejemplares similares
-
Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors
por: Bacher, Jeffery W., et al.
Publicado: (2004) -
Novel In Vitro Assays for the Characterization of EMT in Tumourigenesis
por: Koo, Vincent, et al.
Publicado: (2010) -
A Fast, Sensitive and Accurate High Resolution Melting (HRM) Technology-Based Assay to Screen for Common K-ras Mutations
por: Kramer, D., et al.
Publicado: (2009) -
Comparison of Different Promoter Methylation Assays in Breast Cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010) -
NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)